Master Pharmacokineticist
US Food & Drug Administration
Anuradha (Anu) Ramamoorthy, Ph.D., FCP is a Policy Lead at the Office of Clinical Pharmacology (OCP), Food and Drug Administration (FDA). In her current role, she contributes to regulatory policy development, stakeholder engagement, and research focused on clinical pharmacology. Prior to this role, she was a Reviewer in the Genomics and Targeted Therapy Group (GTTG), OCP contributing to the regulatory review of investigational new drug (IND), new drug application (NDA), and biologic licensing application (BLA) to effectively incorporate pharmacogenomic strategies in drug development. She is co-investigator in a number of regulatory research projects that are focused on advancing the use of genomics, biomarkers and other patient factors in drug development and approval. She published 35 peer-reviewed articles and has presented or chaired 40 sessions at various conferences and workshops. Anu received her Ph.D. in Medical and Molecular Genetics from Indiana University and was a postdoctoral fellow at the National institutes of Health (NIH) and OCP.
Disclosure information not submitted.
Symposium 6: Increasing Diversity in Clinical Trials: What Will It Take for Us to Close the Gap?
Monday, September 9, 2024
8:00 AM – 9:30 AM ET
Monday, September 9, 2024
8:00 AM – 9:30 AM ET